Allergy and Immunology of the Aging Lung

Clinics in Chest Medicine

Volumn 28, Issue 4, 2007, Pages 663-672

  Katial, Rohit ^a   Zheng, Weihong ^a  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLECTIN; TOLL LIKE RECEPTOR;

ADAPTIVE IMMUNITY; AGING; ALLERGY; HOST PATHOGEN INTERACTION; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNITY; IMMUNOLOGY; INNATE IMMUNITY; INTERSTITIAL LUNG DISEASE; LUNG DISEASE; LUNG FUNCTION; LUNG TUMOR; MICROBIAL ACTIVITY; MORBIDITY; MORTALITY; NONHUMAN; PATHOGENESIS; PHAGOCYTE; PHAGOCYTOSIS; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; REVIEW; SENESCENCE;

AGING; ANIMALS; HUMANS; HYPERSENSITIVITY; IMMUNITY, CELLULAR; LUNG;

EID: 35448943506     PISSN: 02725231     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccm.2007.08.005     Document Type: Review

References (97)

1. Marston B.J., Plouffe J.F., File Jr. T.M., et al. Incidence of community-acquired pneumonia requiring hospitalization: results of a population-based active surveillance study in Ohio. The community-based pneumonia incidence study group. Arch Intern Med 157 (1997) 1709-1718
2. Coultas D.B., Zumwalt R.E., Black W.C., et al. The epidemiology of interstitial lung diseases. Am J Respir Crit Care Med 150 (1994) 967-972
3. Hendrick A.M., and Hendrick D.J. Thoracic tumors in the elderly patient. In: Connolly M.J. (Ed). Respiratory disease in the elderly patient (1996), Chapman and Hall, London 141-169
4. National Center for Health Statistics. Health, United States, 2006 with chartbook on trends in the health of Americans. Available at: http://www.cdc.gov/nchs/hus.htm.
5. Marder S.R., Chenoweth D.E., Goldstein I.M., et al. Chemotactic responses of human peripheral blood monocytes to the complement-derived peptides C5a and C5a des Arg. J Immunol 134 (1985) 3325-3331
6. Goldstein I.M., and Weissmann G. Generation of C5-derived lysosomal enzyme-releasing activity (C5a) by lysates of leukocyte lysosomes. J Immunol 113 (1974) 1583-1588
7. Sacks T., Moldow C.F., Craddock P.R., et al. Oxygen radicals mediate endothelial cell damage by complement-stimulated granulocytes: an in vitro model of immune vascular damage. J Clin Invest 61 (1978) 1161-1167
8. Mollnes T.E., Brekke O.L., Fung M., et al. Essential role of the C5a receptor in E. coli-induced oxidative burst and phagocytosis revealed by a novel lepirudin-based human whole blood model of inflammation. Blood 100 (2002) 1869-1877
9. Schnare M., Rollinghoff M., and Qureshi S. Toll-like receptors: sentinels of host defence against bacterial infection. Int Arch Allergy Immunol 139 1 (2006) 75-85 [e-pub 2005 Nov 25]
10. Takeuchi O., Hoshino K., and Akira S. Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection. J Immunol 165 (2000) 5392-5396
11. Torres D., Barrier M., Bihl F., et al. Toll-like receptor 2 is required for optimal control of Listeria monocytogenes infection. Infect Immun 72 (2004) 2131-2139
12. Drennan M.-B., Nicolle D., Quesniaux V.J., et al. Toll-like receptor 2-deficient mice succumb to Mycobacterium tuberculosis infection. Am J Pathol 164 (2004) 49-57
13. Vazquez-Torres A., Vallance B.A., Bergman M.A., et al. Toll-like receptor 4 dependence of innate and adaptive immunity to Salmonella: importance of the Kupffer cell network. J Immunol 172 (2004) 6202-6208
14. Lorenz E., Mira J.P., Cornish K.L., et al. A novel polymorphism in the Toll-like receptor 2 gene and its potential association with staphylococcal infection. Infect Immun 68 (2000) 6398-6401
15. Hawn T.R., Verbon A., Lettinga K.D., et al. A common dominant TLR5 stop codon polymorphism abolishes flagellin signaling and is associated with susceptibility to Legionnaires' disease. J Exp Med 198 (2003) 1563-1572
16. Ogus A.-C., Yoldas B., Ozdemir T., et al. The Arg753GLn polymorphism of the human toll-like receptor 2 gene in tuberculosis disease. Eur Respir J 23 (2004) 219-223
17. Agnese D.-M., Calvano E., Hahm S.J., et al. Human Toll-like receptor 4 mutations but not CD14 polymorphisms are associated with an increased risk of gram-negative infections. J Infect Dis 186 (2002) 1522-1525
18. Lorenz E., Mira J.P., Frees K.L., et al. Relevance of mutations in the TLR4 receptor in patients with gram-negative septic shock. Arch Intern Med 162 (2002) 1028-1032
19. Diamond G., Legarda D., and Ryan L.K. The innate immune response of the respiratory epithelium. Immunol Rev 173 (2000) 27-38
20. Martin T.R., and Frevert C.W. Innate immunity in the lungs. Proc Am Thorac Soc 2 (2005) 403-411
21. Beutler B. Innate immunity: an overview. Mol Immunol 40 12 (2004) 845-859
22. Platz J., Beisswenger C., Dalpke A., et al. Microbial DNA induces a host defense reaction of human respiratory epithelial cells. J Immunol 173 (2004) 1219-1223
23. Skerrett S.J., Liggitt H.D., Hajjar A.M., et al. Respiratory epithelial cells regulate lung inflammation in response to inhaled endotoxin. Am J Physiol Lung Cell Mol Physiol 287 (2004) L143-L152
24. Zhang P., Summer W.R., Bagby G.J., et al. Innate immunity and pulmonary host defense. Immunol Rev 173 (2000) 39-51
25. Curtis J.L., and Kaltreider H.B. Characterization of bronchoalveolar lymphocytes during a specific antibody-forming cell response in the lungs of mice. Am Rev Respir Dis 139 (1989) 393-400
26. Kaltreider H.B., Caldwell J.L., and Byrd P.K. The capacity of normal murine alveolar macrophages to function as antigen-presenting cells for the initiation of primary antibody-forming cell responses to sheep erythrocytes in vitro. Am Rev Respir Dis 133 (1986) 1097-1104
27. Kaltreider H.B., Curtis J.L., and Arraj S.M. The mechanism of appearance of specific antibody-forming cells in lungs of inbred mice after immunization with sheep erythrocytes intratracheally. II. Dose-dependence and kinetics of appearance of antibody-forming cells in hilar lymph nodes and lungs of unprimed and primed mice. Am Rev Respir Dis 135 (1987) 87-92
28. Katial R.K., Brandt B.L., Moran E.E., et al. Immunogenicity and safety testing of a group B meningococcal native outer membrane vesicle vaccine. Infect Immun 70 (2002) 702-707
29. Twigg H.L. Humoral immune defense (antibodies): recent advances. Proc Am Thorac Soc 2 (2005) 417-421
30. Group TBC. Proteins in bronchoalveolar lavage fluid. Am Rev Respir Dis 141 (1990) S183-S188
31. Merrill W.W., Naegel G.P., Olchowski J.J., et al. Immunoglobulin G subclass proteins in serum and lavage fluid of normal subjects: quantitation and comparison with immunoglobulins A and E. Am Rev Respir Dis 131 (1985) 584-587
32. Siber G.R., Schur P.H., Aisenberg A.C., et al. Correlation between serum IgG-2 concentrations and the antibody response to bacterial polysaccharide antigens. N Engl J Med 303 (1980) 178-182
33. Stevens R., Dichek D., Keld B., et al. IgG1 is the predominant subclass of in vivo- and in vitro-produced anti-tetanus toxoid antibodies and also serves as the membrane IgG molecule for delivering inhibitory signals to anti-tetanus toxoid antibody-producing B cells. J Clin Immunol 3 (1983) 65-69
34. Curtis J.L. Cell-mediated adaptive immune defense of the lungs. Proc Am Thorac Soc 2 (2005) 412-416
35. Saltini C., Kirby M., Trapnell B.C., et al. Biased accumulation of T lymphocytes with "memory"-type CD45 leukocyte common antigen gene expression on the epithelial surface of the human lung. J Exp Med 171 (1990) 1123-1140
36. Punturieri A., Alviani R.S., Polak T., et al. Specific engagement of TLR4 or TLR3 does not lead to IFN-ß-mediated innate signal amplification and STAT1 phosphorylation in resident murine alveolar macrophages. J Immunol 173 (2004) 1033-1042
37. Jakubzick C., Kunkel S.L., Puri R.K., et al. Therapeutic targeting of IL-4- and IL-13-responsive cells in pulmonary fibrosis. Immunol Res 30 3 (2004) 339-349
38. Kronenberg M., and Rudensky A. Regulation of immunity by self-reactive T cells. Nature 435 (2005) 598-604
39. + suppressor T cells: more questions than answers. Nat Immun 2 (2002) 389-400
40. Barthlott T., Kassiotis G., and Stockinger B. T cell regulation as a side effect of homeostasis and competition. J Exp Med 197 (2003) 451-460
41. + T cells for IL-2 and exploit it for the induction of IL-10 production. Int Immunol 17 (2005) 279-288
42. + regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 22 (2004) 531-562
43. Asseman C., Mauze S., Leach M.W., et al. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J Exp Med 190 (1999) 995-1004
44. Powrie F., Carlino J., Leach M.W., et al. A critical role for transforming growth factor but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RB(low) CD4+ T cells. J Exp Med 183 (1996) 2669-2674
45. Renshaw M., Rockwell J., Engleman C., et al. Cutting edge: impaired toll-like receptor expression and function in aging. J Immunol 169 (2002) 4697-4701
46. Swift M.E., Burns A.L., Gray K.L., et al. Age-related alterations in the inflammatory response to dermal injury. J Invest Dermatol 117 (2001) 1027-1035
47. Ashcroft G.S., Horan M.A., and Ferguson M.W. Aging alters the inflammatory and endothelial cell adhesion molecule profiles during human cutaneous wound healing. Lab Invest 78 (1998) 47-58
48. McLachlan J. Antitumor properties of aged human monocytes. J Immunol 154 (1995) 832-843
49. Polingnano A. Age-associated changes of neutrophils: responsiveness in a human healthy elderly population. Cytobios 80 (1994) 145-153
50. van Duin D., Mohanty S., Thomas V., et al. Age-associated defect in human TLR-1/2 function. J Immunol 178 (2007) 970-975
51. Flurkey K., Stadecker M., and Miller R.A. Memory T lymphocyte hyporesponsiveness to non-cognate stimuli: a key factor in age-related immunodeficiency. Eur J Immunol 22 (1992) 931-935
52. L gene repertoire and in specificity. J Immunol 147 (1991) 2750-2755
53. Linton P.J., Haynes L., Tsui L., et al. From naive to effector: alterations with aging. Immunol Rev 160 (1997) 9-18
54. Miller R.A., Garcia G., Kirk C.J., et al. Early activation defects in T lymphocytes from aged mice. Immunol Rev 160 (1997) 79-90
55. Zhou T., Edwards C.K., and Mountz J.K. Prevention of age-related T cell apoptosis defect in CD2-fas transgenic mice. J Exp Med 182 (1995) 129-137
56. Jackola D.R., Ruger J.K., and Miller R.A. Age-associated changes in human T cell phenotype and function. Aging (Milano) 6 (1994) 25-34
57. 2 T cell subpopulations in the elderly. Mech Ageing Dev 87 (1996) 197-209
58. Liu J., Wang S., Liu H., et al. The monitoring biomarker for immune function of lymphocytes in the elderly. Mech Ageing Dev 94 (1997) 177-182
59. Song H., Price P.W., and Cerny J. Age-related changes in antibody repertoire: contribution from T-cells. Immunol Rev 160 (1997) 55-62
60. Masanori U., Hirokawa K., Kurashima C., et al. Differential age-change in the numbers of CD4+CD45RA+ and CD4+CD29+ T cell subsets in human peripheral blood. Mech Ageing Dev 63 (1992) 57-68
61. Amadori A., Zamarchi R., de Silvestro G., et al. Genetic control of the CD4/CD8 T-cell ratio in humans. Nat Med 1 (1995) 1279-1283
62. Meyer K.C., Ershler W., Rosenthal N., et al. Immune dysregulation in the aging human lung. Am J Respir Crit Care Med 153 (1996) 1072-1079
63. Agostini C., Chilosi M., Zambello R., et al. Pulmonary immune cells in health and disease: lymphocytes. Eur Respir J 6 (1993) 1378-1401
64. Berman J.S., Beer D.J., Theodore A.C., et al. Lymphocyte recruitment to the lung. Am Rev Respir Dis 142 (1990) 238-257
65. The BAL Cooperative Group Steering Committee. Bronchoalveolar lavage constituents in healthy individuals, idiopathic pulmonary fibrosis, and selected comparison groups. Am Rev Respir Dis 141 Suppl (1990) S169-S202
66. Meyer K.C., and Soergel P. Bronchoalveolar lymphocyte phenotypes change in the normal aging human lung. Thorax 54 (1999) 697-700
67. Franceschi C., Bonafe M., and Valensin S. Human immunosenescence: the prevailing of innate immunity, the failing of clonotypic immunity, and the filling of immunological space. Vaccine 18 (2000) 1717-1720
68. Franceschi C., and Bonafe M. Centenarians as a model for healthy aging. Biochem Soc Trans 31 (2003) 457-461
69. Francheschi C., Monti D., Samsoni P., et al. The immunology of exceptional individuals: the lesson of centenarians. Immunol Today 16 (1995) 12-16
70. Ferguson F.G., Wikby A., Maxon P., et al. Immune parameters in a longitudinal study of a very old population of Swedish people: a comparison between survivors and nonsurvivors. J Gerontol 50 (1995) B378-B382
71. Smaldone G.C. Deposition and clearance: unique problems in the proximal airways and oral cavity in the young and elderly. Respir Physiol 128 (2001) 33-38
72. Ho J.C., Chan K.N., Hu W.H., et al. The effect of aging on nasal mucociliary clearance, beat frequency, and ultrastructure of respiratory cilia. Am J Respir Crit Care Med 163 (2001) 983-988
73. Kikuchi R., Watabe N., Konno T., et al. High incidence of silent aspiration in elderly patients with community-acquired pneumonia. Am J Respir Crit Care Med 150 (1994) 251-253
74. Riquelme R., Torres A., El-Ebiary M., et al. Community-acquired pneumonia in the elderly: a multivariate analysis of risk and prognostic factors. Am J Respir Crit Care Med 154 (1996) 1450-1455
75. Strausbaugh L.J., Sukumar S.R., and Joseph C.L. Infectious disease outbreaks in nursing homes: an unappreciated hazard for frail elderly persons. Clin Infect Dis 36 (2003) 870-876
76. Bauer B.A., Reed C.E., and Yunginger J.W. Incidence and outcomes of asthma in the elderly: a population-based study in Rochester, Minnesota. Chest 111 (1997) 303-310
77. Yunginger J.W., Reed C.E., O'Connell E.J., et al. A community-based study of the epidemiology of asthma: incidence rates, 1964. Am Rev Respir Dis 146 (1992) 888-894
78. Burrows B., Barbee R.A., Cline M.G., et al. Characteristics of asthma among elderly adults in a sample of the general population. Chest 100 (1991) 935-942
79. Dodge R.R., and Burrows B. The prevalence and incidence of asthma and asthma-like symptoms in a general population sample. Am Rev Respir Dis 122 (1980) 567-575
80. Burrows B., Lebowitz M.D., Barbee R.A., et al. Findings before diagnoses of asthma among the elderly in a longitudinal study of a general population sample. J Allergy Clin Immunol 88 (1991) 870-877
81. Sunyer J., Anto J.M., Castellsagué J., et al. Total serum IgE is associated with asthma independently of specific IgE levels: the Spanish Group of the European Study of Asthma. Eur Respir J 9 (1996) 1880-1884
82. Tollerud D.J., O'Connor G.T., Sparrow D., et al. Asthma, hay fever, and phlegm production associated with distinct patterns of allergy skin test reactivity, eosinophilia, and serum IgE levels: the Normative Aging Study. Am Rev Respir Dis 144 (1991) 776-781
83. Almind M., Viskum K., Evald T., et al. A seven-year follow-up study of 343 adults with bronchial asthma. Dan Med Bull 39 (1992) 561-565
84. Sunyer J., Anto J.M., Sabria J., et al. Relationship between serum IgE and airway responsiveness in adults with asthma. J Allergy Clin Immunol 95 (1995) 699-706
85. Eschenbacher W.L., Holian A., and Campion R.J. Air toxics and asthma: impacts and end points. Environ Health 103 Suppl 6 (1995) 209-211
86. Castellsague J., Sunyer J., Saez M., et al. Short-term association between air pollution and emergency room visits for asthma in Barcelona. Thorax 50 (1995) 1051-1056
87. Zeleznik J. Normative aging of the respiratory system. Clin Geriatr Med 19 1 (2003) 1-18
88. McClaran S.R., Babcock M.A., Pegelow D.F., et al. Longitudinal effects of aging on lung function at rest and exercise in healthy active fit elderly adults. J Appl Physiol 78 (1995) 1957-1968
89. Mittman C., Edelman N.H., Norris A.H., et al. Relationship between chest wall and pulmonary compliance with age. J Appl Physiol 20 (1965) 1211-1216
90. Knudson R.J., Clark D.F., Kennedy T.C., et al. Effect of aging alone on mechanical properties of the normal adult human lung. J Appl Physiol 43 (1977) 1054-1062
91. Gibson G.J., Pride N.B., O'Cain C., et al. Sex and age differences in pulmonary mechanics in normal nonsmoking subjects. J Appl Physiol 41 (1976) 20-25
92. Crapo R.O., Morris A.H., and Gardner R.M. Reference spirometric values using techniques and equipment that meet ATS recommendations. Am Rev Respir Dis 123 (1981) 659-664
93. Knudson R.J., Lebowitz M.D., Holberg C.J., et al. Changes in the normal maximal expiratory flow volume curve with growth and aging. Am Rev Respir Dis 127 (1983) 725-734
94. Burrows B., Lebowitz M.D., Camilli A.E., et al. Longitudinal changes in forced expiratory volume in one second in adults. Am Rev Respir Dis 133 (1986) 974-980
95. Tager I.B., Segal M.R., Speizer F.E., et al. The natural history of forced expiratory volumes: effect of cigarette smoking and respiratory symptoms. Am Rev Respir Dis 138 (1988) 837-849
96. Gottlieb D.J., Sparrow D., O'Connor G.T., et al. Skin test reactivity to common aeroallergens and decline of lung function: the Normative Aging Study. Am J Respir Crit Care Med 153 2 (1996) 561-566
97. O'Connor G.T., Sparrow D., Segal M., et al. Risk factors for ventilatory impairment among middle-aged and elderly men: the Normative Aging Study. Chest 103 (1993) 376-382